Pharmatest Services
Biotechnology Research • 
Turku, Southwest Finland, Finland • 11-20 Employees
Company overview
| Headquarters | Itäinen Pitkäkatu 4 A, Turku, 20520, FI |
| Phone number | +35822784700 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Cancer, Assay Development, Bone Analysis, Drug Development, Drug Discovery, Efficacy Testing, Hormonal Action, Model Development, Osteoarthritis, Osteoporosis, Preclinical Research, Safety Testing, Radiotherapy, In Vitro Assays, Osteogenesis Imperfecta, In Vivo Models, Bone Metastasis, Clinical Biomarker Services, Metastasis Models, Oncology Cro, Pain Assesment, Preclinical Efficacy, Skeletal Disease Models, Rare Bone Disease, Ex Vivo Analyses |
| Founded | 1998 |
| Employees | 11-20 |
| Socials |
Key Contact at Pharmatest Services
Katja Fagerlund
Research Director
Pharmatest Services Email Formats
Pharmatest Services uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@pharmatest.com), used 81.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@pharmatest.com | 81.8% |
{first name}.{last name} | john.doe@pharmatest.com | 18.2% |
About Pharmatest Services
Pharmatest Services (Pharmatest) is a preclinical contract research organization offering translational research services for diseases with unmet clinical needs. We offer full-service research solutions for early drug development. Our focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, we provide model and assay development services for our customers. Pharmatest can help you establish the proof-of-efficacy of your cancer drug candidates with clinically predictive cell culture assays, organotypic 3D models, orthotopic animal models, and disseminated cancer models. Our models of skeletal diseases include clinically predictive bone cell culture assays and animal models of osteoporosis and osteoarthritis that can also be used for bone safety testing. Our services have been developed with just one goal in mind – to make your nonclinical drug development faster and more predictive. Our mission is to reduce the amount of drug candidates failing in clinical trials. Outsource your preclinical efficacy testing to Pharmatest and increase significantly the speed of your drug development with reduced costs.
Pharmatest Services revenue & valuation
| Annual revenue | $1,625,545 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Pharmatest Services Tech Stack
Discover the technologies and tools that power Pharmatest Services's digital infrastructure, from frameworks to analytics platforms.
Security
Miscellaneous
JavaScript libraries
Page builders
JavaScript libraries
SEO
JavaScript libraries
Web servers
Advertising
Miscellaneous
Programming languages
Canada
United States
Israel
AustraliaFrequently asked questions
4.8
40,000 users
